# To Study the Role of Liquid Based Cytology (LBC) for Diagnosis and Characterization of Biliopancreatic Tumor s Compared With Standard Cytology and On-site Evaluation.

> **NCT04022408** · NA · UNKNOWN · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 60 (estimated)

## Conditions studied

- Pancreatobiliary-Type Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Liquid based cytology
- **DIAGNOSTIC_TEST:** Conventional cytology

## Key facts

- **NCT ID:** NCT04022408
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-08
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-10-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04022408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04022408, "To Study the Role of Liquid Based Cytology (LBC) for Diagnosis and Characterization of Biliopancreatic Tumor s Compared With Standard Cytology and On-site Evaluation.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04022408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*